Drug intelligence / Profile preview

qiangjijianli

Development stage: Preclinical
Administration: Oral

Overview

Qiangjijianli (强肌健力方) is a traditional Chinese medicine prescription. It has been studied for its effects on cytokine levels in animal models of spleen asthenia, suggesting it may have immunomodulatory or tonic properties. The formula likely contains multiple herbal ingredients and is used within the context of traditional Chinese medicine to strengthen the body and improve vitality, particularly in conditions associated with weakness or deficiency[3].

Other names: Qiangjijianli Prescription强肌健力方

Beyond the preview

Go deeper on qiangjijianli.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on qiangjijianli.

Explore the full profile